L Bianchi Selected Research

L Bianchi Research Topics

Disease

33	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 07/2003
14	Chronic Obstructive Pulmonary Disease (COPD) 10/2015 - 03/2000
8	Hidradenitis Suppurativa 07/2021 - 01/2019
7	Psoriatic Arthritis 03/2022 - 02/2017
7	Hepatocellular Carcinoma (Hepatoma) 09/2010 - 01/2000
6	Atopic Dermatitis (Atopic Eczema) 08/2022 - 01/2019
5	Necrosis 01/2021 - 11/2008
4	COVID-19 08/2022 - 12/2020
4	Hypersensitivity (Allergy) 11/2021 - 12/2002
4	Infections 02/2018 - 07/2000
4	Inflammation (Inflammations) 03/2016 - 08/2004
3	Pain (Aches) 01/2021 - 01/2009
3	Obesity 11/2019 - 07/2016
3	Hypercapnia 10/2017 - 09/2000
3	Neoplasms (Cancer) 03/2016 - 05/2001
3	Insulin Resistance 12/2014 - 11/2000
3	Body Weight (Weight, Body) 12/2014 - 07/2013
3	Respiratory Insufficiency (Respiratory Failure) 02/2009 - 06/2000
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022 - 07/2016
2	Eczema 08/2022 - 01/2020
2	Basal Cell Carcinoma (Rodent Ulcer) 12/2021 - 07/2004
2	Abscess 01/2021 - 06/2020
2	Exanthema (Rash) 01/2020 - 12/2002
2	Nasopharyngitis 06/2017 - 12/2016
2	Headache (Headaches) 06/2017 - 12/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 06/2017 - 12/2016
2	Arthralgia (Joint Pain) 06/2017 - 12/2016
2	Overweight 02/2017 - 07/2013
2	Schizophrenia (Dementia Praecox) 11/2015 - 07/2015
2	Melanoma (Melanoma, Malignant) 02/2009 - 08/2001
2	Neoplasm Metastasis (Metastasis) 01/2009 - 04/2007
2	Glioma (Gliomas) 01/2004 - 01/2000
2	Hepatitis 12/2002 - 09/2001
2	Pulmonary Heart Disease (Cor Pulmonale) 05/2002 - 08/2000
2	Chronic Hepatitis C 10/2001 - 07/2000
2	Schistosomiasis (Bilharziasis) 09/2001 - 07/2000
2	Lipodystrophy 02/2001 - 11/2000
2	Hyperthermia 12/2000 - 01/2000
2	Colitis 07/2000 - 04/2000
1	Granuloma Annulare 12/2021

Drug/Important Bio-Agent (IBA)

9	Adalimumab (Humira)FDA Link 01/2021 - 01/2014
6	Monoclonal AntibodiesIBA 08/2021 - 06/2001
6	secukinumabIBA 07/2021 - 09/2018
6	Pharmaceutical PreparationsIBA 02/2018 - 06/2000
6	Proteins (Proteins, Gene)FDA Link 07/2016 - 08/2001
6	GasesIBA 09/2005 - 03/2000
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2002 - 03/2000
5	Biological ProductsIBA 01/2021 - 08/2001
5	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 01/2000
5	Interleukin-17 (Interleukin 17)IBA 01/2020 - 06/2017
5	Biomarkers (Surrogate Marker)IBA 07/2016 - 10/2007
5	Taurine FDA Link 01/2004 - 01/2000
4	dupilumabIBA 08/2022 - 08/2020
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 04/2014
4	brodalumabIBA 01/2021 - 12/2016
4	Ustekinumab (CNTO 1275)FDA Link 01/2020 - 08/2017
4	CytokinesIBA 11/2019 - 09/2001
4	LipidsIBA 12/2014 - 06/2011
4	gamma-Aminobutyric Acid (GABA)IBA 01/2004 - 01/2000
3	apremilastIBA 03/2022 - 03/2017
3	ixekizumabIBA 01/2020 - 01/2019
3	AutoantibodiesIBA 01/2020 - 04/2012
3	Interleukin-6 (Interleukin 6)IBA 12/2014 - 01/2014
3	Oxygen (Dioxygen)IBA 12/2011 - 07/2001
3	tazarotene (Tazorac)FDA Link 07/2004 - 07/2003
2	risankizumabIBA 02/2022 - 03/2021
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 01/2019
2	Biosimilar PharmaceuticalsIBA 01/2021 - 12/2017
2	etanercept biosimilar SB4IBA 11/2019 - 01/2019
2	Interleukin-23 (Interleukin 23)IBA 11/2019 - 07/2018
2	InterleukinsIBA 11/2019 - 07/2018
2	Insulin (Novolin)FDA Link 10/2019 - 12/2014
2	Interleukin-22 (IL-22)IBA 07/2018 - 01/2014
2	Infliximab (Remicade)FDA Link 12/2017 - 01/2014
2	Carbon DioxideIBA 10/2017 - 09/2000
2	Complement System Proteins (Complement)IBA 10/2015 - 05/2013
2	AdiponectinIBA 12/2014 - 07/2013
2	C-Reactive ProteinIBA 12/2014 - 04/2014
2	Ethanol (Ethyl Alcohol)IBA 11/2006 - 05/2001
2	Glutamic Acid (Glutamate)FDA Link 01/2004 - 01/2000
2	Aspartic Acid (Aspartate)FDA Link 01/2004 - 01/2000
2	Amino Acids FDA Link 01/2004 - 01/2000
2	prednylidene (Pred)IBA 05/2002 - 05/2002
2	Human immunodeficiency virus 1 p16 proteaseIBA 02/2001 - 11/2000
2	NucleosidesIBA 02/2001 - 11/2000
2	Protease Inhibitors (Protease Inhibitor)IBA 02/2001 - 11/2000
2	Reverse Transcriptase InhibitorsIBA 02/2001 - 11/2000
2	RNA (Ribonucleic Acid)IBA 11/2000 - 07/2000
1	tildrakizumabIBA 10/2022
1	Phosphodiesterase 4 InhibitorsIBA 03/2022
1	HhAntag691IBA 12/2021
1	AcrylatesIBA 11/2021
1	Interleukin-4 (Interleukin 4)IBA 08/2021

Therapy/Procedure

15	Therapeutics 03/2022 - 04/2000
5	Biological Therapy 12/2020 - 02/2017
5	Artificial Respiration (Mechanical Ventilation) 12/2011 - 06/2000
4	Liver Transplantation 09/2010 - 07/2000
3	Interactive Ventilatory Support 05/2002 - 06/2000
2	Aftercare (After-Treatment) 07/2015 - 11/2006
2	Catheters 09/2001 - 01/2000